Home › Diffuse Large B-Cell Lymphoma › Nevada

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Nevada

3 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa Nevada.

Mga Lungsod sa Nevada

Las Vegas3 pag-aaral

Opisyal na teksto ng pag-aaral (English)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Comprehensive Cancer Centers of Nevada, Las Vegas

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Comprehensive Cancer Centers of Nevada ( Site 0168), Las Vegas

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05139017

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

OptumCare Cancer Care ( Site 0121), Las Vegas
Comprehensive Cancer Centers of Nevada ( Site 0113), Las Vegas
Cancer Care Specialists ( Site 9582), Reno

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06717347

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.